TMO in the 13F filings
Thermo Fisher Scientific Inc · CUSIP 883556102
- Quarter end
- 31 Dec 2025
- the date the book describes
- Filed
- 27 Oct 2026
- latest of these filings; the earliest 22 Jan 2026
- Managers listing it
- 45
- at least, of 95 tracked, among listed positions
- Comparable managers
- 92
- filed both Q3 2025 and Q4 2025; 29 listed it in both
- Shares listed
- 52,150,282
- combined, among listed positions
- Reported value
- $30.2bn
- combined, at the quarter end
Among the 92 comparable managers: 27 buyers (opened or added shares) and 20 sellers (trimmed or exited), at least, among listed positions. Their net change in shares was +5,857,143.
Managers listing TMO in Q4 2025
45 of 45 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 9,793,347 shares now+2,199,538
- T. Rowe Price Associates Incexisting position · 7,701,353 shares now+1,230,872
- Viking Global Investors LPnew position · 793,187 shares now+793,187
- Wellington Management Group LLPexisting position · 3,468,240 shares now+768,780
- Capital World Investorsexisting position · 11,003,814 shares now+718,669
Reductions
- Farallon Capital Management LLCexisting position · 635,685 shares now-622,556
- Millennium Management LLCexisting position · 52,264 shares now-444,827
- Arrowstreet Capital LPexisting position · 867,512 shares now-398,613
- Capital Research Global Investorsexisting position · 2,914,901 shares now-247,761
- Janus Henderson Group Ltdexisting position · 1,096,959 shares now-140,903
New positions and exits
New (5)
Exited (5)
- Freestone Grove Partners LPwas $83m
- Soroban Capital Partners LPwas $40m
- Winton Group Ltdwas $14m
- Quantbot Technologies LPwas $2.1m
- Hudson Bay Capital Management LPwas $376k
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 19 | $8.8bn | n.a. | n.a. |
| Q3 2013 | 19 | $10.1bn | n.a. | n.a. |
| Q4 2013 | 19 | $12.6bn | n.a. | n.a. |
| Q1 2014 | 22 | $12.8bn | n.a. | n.a. |
| Q2 2014 | 22 | $12.9bn | n.a. | n.a. |
| Q3 2014 | 22 | $13.6bn | n.a. | n.a. |
| Q4 2014 | 30 | $14.7bn | n.a. | n.a. |
| Q1 2015 | 27 | $15.0bn | n.a. | n.a. |
| Q2 2015 | 27 | $14.1bn | n.a. | n.a. |
| Q3 2015 | 20 | $13.5bn | n.a. | n.a. |
| Q4 2015 | 21 | $15.4bn | n.a. | n.a. |
| Q1 2016 | 21 | $14.7bn | n.a. | n.a. |
| Q2 2016 | 20 | $14.9bn | n.a. | n.a. |
| Q3 2016 | 18 | $15.7bn | n.a. | n.a. |
| Q4 2016 | 31 | $13.2bn | n.a. | n.a. |
| Q1 2017 | 27 | $13.8bn | n.a. | n.a. |
| Q2 2017 | 29 | $15.7bn | n.a. | n.a. |
| Q3 2017 | 28 | $17.9bn | n.a. | n.a. |
| Q4 2017 | 20 | $18.2bn | n.a. | n.a. |
| Q1 2018 | 28 | $20.1bn | n.a. | n.a. |
| Q2 2018 | 27 | $19.9bn | n.a. | n.a. |
| Q3 2018 | 27 | $23.6bn | n.a. | n.a. |
| Q4 2018 | 30 | $21.6bn | n.a. | n.a. |
| Q1 2019 | 30 | $27.4bn | n.a. | n.a. |
| Q2 2019 | 33 | $28.8bn | n.a. | n.a. |
| Q3 2019 | 26 | $27.9bn | n.a. | n.a. |
| Q4 2019 | 26 | $30.3bn | n.a. | n.a. |
| Q1 2020 | 27 | $25.8bn | n.a. | n.a. |
| Q2 2020 | 29 | $32.6bn | n.a. | n.a. |
| Q3 2020 | 29 | $38.9bn | n.a. | n.a. |
| Q4 2020 | 33 | $39.2bn | n.a. | n.a. |
| Q1 2021 | 35 | $36.5bn | n.a. | n.a. |
| Q2 2021 | 33 | $38.3bn | n.a. | n.a. |
| Q3 2021 | 32 | $42.6bn | n.a. | n.a. |
| Q4 2021 | 38 | $50.1bn | n.a. | n.a. |
| Q1 2022 | 32 | $43.2bn | n.a. | n.a. |
| Q2 2022 | 33 | $38.9bn | n.a. | n.a. |
| Q3 2022 | 26 | $34.3bn | n.a. | n.a. |
| Q4 2022 | 29 | $37.0bn | n.a. | n.a. |
| Q1 2023 | 35 | $37.1bn | n.a. | n.a. |
| Q2 2023 | 39 | $33.5bn | n.a. | n.a. |
| Q3 2023 | 39 | $32.6bn | n.a. | n.a. |
| Q4 2023 | 41 | $32.7bn | 19 | 23 |
| Q1 2024 | 30 | $34.1bn | 14 | 18 |
| Q2 2024 | 38 | $30.6bn | 25 | 18 |
| Q3 2024 | 30 | $33.8bn | 12 | 19 |
| Q4 2024 | 36 | $27.6bn | 22 | 15 |
| Q1 2025 | 31 | $24.2bn | 12 | 22 |
| Q2 2025 | 39 | $18.8bn | 27 | 11 |
| Q3 2025 | 32 | $21.9bn | 22 | 13 |
| Q4 2025 | 32 | $29.9bn | 27 | 20 |
| Q1 2026 | 34 | $24.4bn | 23 | 23 |
| Q2 2026 | 36 | $26.4bn | 27 | 22 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
TMO and LLY →TMO and JNJ →TMO and VRTX →Choose a stock to compare with TMO →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own TMO, latest filings →Back to the 13F Explorer →